Table of Contents
1. EXECUTIVE SUMMARY
- Summary of Major Findings
2. RESEARCH SCOPE AND METHODOLOGY
3. INTRODUCTION
- Introduction
- 1. Research Study Overview
- 2. Cancer
4. TYPES OF CANCER
- Introduction
- 1. Introduction to Types of Cancers
- Breast Cancer
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Lung Cancer
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Colon Cancer
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Prostate Cancer
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Leukemia
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Lymphoma
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
- Uterine Cancer
- 1. Introduction
- 2. Staging
- 3. Treatment Modality
- 4. Issues and Trends
- 5. Prevalence
5. MARKET OUTLOOK
- Introduction
- Industry Challenges
- 1. Challenges in the European Market
- Drivers and Restraints
- Key Market Participants and Products Available
- 1. Key Market Participants
- 2. Key Products
- Country Profile
- 1. Germany
- 2. France
- 3. Italy
- 4. Spain
- 5. United Kingdom
- 6. Benelux
- 7. Scandinavia
- Radiotherapy Resources
- 1. Radiotherapy Resources in Europe
- Treatment Distribution
- 1. Treatment Distribution in Europe
6. THINKING OUTSIDE THE BOX
- Competitive Structure and Opportunities
- 1. Competitive Structure
- 2. Opportunities
- Future Outlook
- 1. A Future Outlook for the European Industry
- Conclusion
- 1. Radiotherapy Devices- Conclusion
7. DECISION SUPPORT DATABASE
- Database
- 1. Number of Hospitals- Western Europe
- 2. Private Healthcare Expenditure
- 3. Government Healthcare Expenditure
- 4. Population Aged 65 and above
- 5. Per Capita Healthcare Expenditure
|
Related Report
|